Entera Bio Ltd (ENTX)
NASDAQ:ENTX
Holding ENTX?
Track your performance easily

Entera Bio (ENTX) Financial Statements

398 Followers

Entera Bio Financial Overview

Entera Bio's market cap is currently ―. The company's EPS TTM is $-0.26; its P/E ratio is -6.42; Entera Bio is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 42.00K$ 57.00K---
Gross Profit-$ 9.00K---
EBIT$ -3.02M$ -2.15M$ -2.02M$ -1.96M$ -2.39M
EBITDA$ -3.01M$ -2.13M$ -2.00M$ -1.95M$ -2.37M
Net Income Common Stockholders$ -3.02M$ -2.15M$ -2.02M$ -2.00M$ -2.38M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.92M$ 9.06M$ 9.19M$ 11.02M$ 7.58M
Total Assets$ 7.74M$ 10.04M$ 10.24M$ 11.77M$ 8.56M
Total Debt$ 309.00K$ 334.00K$ 377.00K$ 390.00K$ 402.00K
Net Debt$ -6.61M$ -8.72M$ -8.81M$ -10.63M$ -7.18M
Total Liabilities$ 1.29M$ 1.50M$ 1.38M$ 1.38M$ 2.33M
Stockholders Equity$ 6.45M$ 8.53M$ 8.86M$ 10.39M$ 6.24M
Cash Flow-
Free Cash Flow$ -2.15M$ -1.33M$ -1.86M$ -2.62M$ -1.52M
Operating Cash Flow$ -2.15M$ -1.33M$ -1.86M$ -2.62M$ -1.52M
Investing Cash Flow---$ -5.00K-
Financing Cash Flow$ 13.00K$ 1.22M$ 30.00K$ 6.03M-
Currency in USD

Entera Bio Earnings and Revenue History

Entera Bio Debt to Assets

Entera Bio Cash Flow

Entera Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis